IRMELA SALIHOVIC: Open Payments
NPI 1013623289 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 69 payments from 12 companies in 2025. Trend: 2023 $1,427 · 2024 $1,430 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $278 |
| PFIZER INC. | 10 | $188 |
| Novo Nordisk Inc | 9 | $160 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| BridgeBio Pharma, Inc. | 2 | $32 |
Products named: LEQVIO, Wegovy, VYNDAQEL, ELIQUIS, Kerendia, VERQUVO, JARDIANCE, LifeVest.
Industry payments across IA — which companies pay providers there.
